Verra Therapeutics, Inc. — Form D

Verra Therapeutics, Inc. of LANSING, NY, a company, filed a Form D exempt-offering notice with the SEC on 2026-02-18. The offering totals $450K, of which $205K was reported sold. Industry: Biotechnology.

Offering

• Filed: 2026-02-18
• Form: D
• Accession: 0002111997-26-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $450K
• Amount sold: $205K
• Remaining: $245K
• Minimum investment: $10K
• Investors: 6
• Date of first sale: 2024-12-16
• Security types: equity
• Revenue range: $1 - $1,000,000
• SEC file number: 021-573922

Issuer

• Name: Verra Therapeutics, Inc.
• CIK: 0002111997
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2024
• Address: 1939 EAST SHORE DR. SUITE 5, LANSING, NY, 14882
• Phone: 607 227 6828

Officers, directors & promoters (3)

More

• CIK 2111997 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search